Get more insights into the Swiss biotech industry by checking out these company profiles that share their answers to these questions:
Microsynth (founded in 1989) is a leading European company in nucleic acid synthesis & analysis. The main activities are divided into these business areas: DNA/RNA synthesis - DNA/RNA analysis and sequencing - Contract research/outsourcing
Pheida develops and deploys biotech solutions at scale to reduce GHG emissions and other pollutants, and to remediate contaminated soil and water. Pheida products combine advanced biotech, proprietary application engineering to deliver unique and commercially attractive solutions.
MUVON Therapeutics is a Swiss clinical stage biotech company with the goal of revolutionizing the treatment of various diseases caused by muscle damage or degradation through the use of the patients' own cells. Our initial area of focus is the treatment of stress urinary incontinence in women.
CDR-Life is a biopharmaceutical company that develops tumor targeted immunotherapies. The company has a uniquely powerful platform technology to target intracellular tumor antigens with highly potent and specific T cell engagers.
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.
Somagenetix is a spin-off from the University of Zurich leveraging scientific, clinical & commercial expertise to solve unmet medical needs. With Phagocure, our gene therapy platform, we aim at becoming a leading company with first & best-in-class treatments for phagocyte-related disorders.
Tigen is a Swiss clinical stage biotech company developing cell therapies to cure cancer. A disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class capabilities and a long-term perspective to accelerate access to novel T-cell therapies for patients and society.
Advanced Clinical is a privately held clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of those touched by clinical research and help our clients get better outcomes.
Aptissen is specialized in the development, distribution, and marketing of viscosupplements (Synolis VA) and drinkable food supplement (Cartylis) in the area of joint health.
As a member of the Swiss Biotech Association, you can add company insights to your company portrait in the digital Swiss Biotech Directory by answering a couple of our questions, and to appear on this special feature page.